Skip to main content

Nektar Therapeutics

NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000906709

In the last 90 days, Nektar Therapeutics insiders filed 0 open-market purchases and 3 sales; 239 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.

13F holders, Q1 2025

Institutional positions in Nektar Therapeutics as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
157
+13 vs. Q4 2024
Shares held
123.8M
−8.76M (−6.6%) vs. Q4 2024
Total value
$84.2M
−$39.1M (−31.7%) vs. Q4 2024
New holders
30
42 more added
Sold out
17
48 more reduced

2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting NKTR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2025: 157 institutions
Q1 2021: 239 institutionsQ2 2021: 243 institutionsQ3 2021: 243 institutionsQ4 2021: 242 institutionsQ1 2022: 243 institutionsQ2 2022: 230 institutionsQ3 2022: 232 institutionsQ4 2022: 217 institutionsQ1 2023: 197 institutionsQ2 2023: 148 institutionsQ3 2023: 139 institutionsQ4 2023: 127 institutionsQ1 2024: 123 institutionsQ2 2024: 135 institutionsQ3 2024: 140 institutionsQ4 2024: 146 institutionsQ1 2025: 157 institutionsQ2 2025: 109 institutionsQ3 2025: 153 institutionsQ4 2025: 180 institutionsQ1 2026: 216 institutionsQ2 2026: 239 institutions
Value heldQ1 2025: $84.2M
Q1 2021: $3.40BQ2 2021: $2.89BQ3 2021: $3.01BQ4 2021: $2.35BQ1 2022: $947.6MQ2 2022: $693.8MQ3 2022: $561.4MQ4 2022: $381.7MQ1 2023: $121.2MQ2 2023: $79.3MQ3 2023: $85.3MQ4 2023: $67.3MQ1 2024: $105.5MQ2 2024: $168.0MQ3 2024: $182.9MQ4 2024: $123.6MQ1 2025: $84.2MQ2 2025: $197.7MQ3 2025: $820.2MQ4 2025: $732.2MQ1 2026: $1.94BQ2 2026: $2.50B
Institutions holding NKTR and their total value by quarter
QuarterHoldersValue
Q2 2026239$2.50B
Q1 2026216$1.94B
Q4 2025180$732.2M
Q3 2025153$820.2M
Q2 2025109$197.7M
Q1 2025157$84.2M
Q4 2024146$123.6M
Q3 2024140$182.9M
Q2 2024135$168.0M
Q1 2024123$105.5M
Q4 2023127$67.3M
Q3 2023139$85.3M
Q2 2023148$79.3M
Q1 2023197$121.2M
Q4 2022217$381.7M
Q3 2022232$561.4M
Q2 2022230$693.8M
Q1 2022243$947.6M
Q4 2021242$2.35B
Q3 2021243$3.01B
Q2 2021243$2.89B
Q1 2021239$3.40B

Institutions, Q1 2025

Shares, value and share of portfolio for each institution holding Nektar Therapeutics; share changes are against Q4 2024.

Institutions holding NKTR in Q1 2025
InstitutionSharesValue% of portfolioChange in sharesAction
FMR LLC233,964$159.1K0.00%−280,400−54.5%Reduced
Barclays PLC236,778$161.0K0.00%−89,040−27.3%Reduced
Macquarie Group Ltd256,385$174.0K0.00%00.0%Unchanged
Price T Rowe Associates Inc256,378$175.0K0.00%+63,400+32.9%Added
Voya Investment Management LLC266,773$181.4K0.00%+85,094+46.8%Added
BNP Paribas Arbitrage, SA292,087$198.6K0.00%−20,606−6.6%Reduced
Ameriprise Financial Inc309,428$210.4K0.00%−64,520−17.3%Reduced
Nuveen, LLC326,716$222.2K0.00%+326,716New
UBS Group AG327,310$222.6K0.00%+21,381+7.0%Added
Simplex Trading, LLC343,935$233.0K0.01%+331,258+2,613.1%Added
Group One Trading, L.P.351,143$238.8K0.01%+351,143New
Connor, Clark & Lunn Investment Management Ltd.368,304$250.4K0.00%−362,571−49.6%Reduced
Dimensional Fund Advisors LP373,654$254.5K0.00%−119,985−24.3%Reduced
Bank of New York Mellon Corp393,293$267.4K0.00%−17,023−4.1%Reduced
Gilder Gagnon Howe & Co LLC412,379$280.4K0.00%+412,379New
Boothbay Fund Management, LLC432,739$294.3K0.01%−123,137−22.2%Reduced
Citadel Advisors LLC491,195$334.0K0.00%+94,154+23.7%Added
JPMorgan Chase & Co491,246$334.0K0.00%−691,749−58.5%Reduced
Fred Alger Management, LLC506,446$344.4K0.00%+506,446New
Goldman Sachs Group Inc531,362$361.3K0.00%−196,024−26.9%Reduced
Susquehanna International Group, LLP557,207$378.9K0.00%+473,906+568.9%Added
Ieq Capital, LLC557,222$378.9K0.00%+535,244+2,435.4%Added
Deuterium Capital Management, LLC560,235$381.0K0.85%+560,235New
Peapod Lane Capital LLC577,238$392.5K0.44%−530,278−47.9%Reduced
Morgan Stanley584,117$397.2K0.00%−218,225−27.2%Reduced
Invesco Ltd.623,218$423.8K0.00%−32,308−4.9%Reduced
Prelude Capital Management, LLC670,149$455.7K0.05%+486,736+265.4%Added
CM Management, LLC800,000$544.0K0.55%+50,000+6.7%Added
Balyasny Asset Management LLC850,115$578.1K0.00%+850,115New
Bridgeway Capital Management, LLC992,100$674.6K0.02%−300,000−23.2%Reduced
Armistice Capital, LLC1,036,000$704.5K0.02%+12,000+1.2%Added
Altium Capital Management LP1,051,379$714.9K2.08%−1,948,621−65.0%Reduced
Monaco Asset Management SAM1,068,899$726.9K0.37%−963,969−47.4%Reduced
Union Square Park Capital Management, LLC1,100,000$748.0K0.82%+1,100,000New
Northern Trust Corp1,417,166$963.7K0.00%+2,182+0.2%Added
Two Sigma Advisers, LP1,420,542$966.0K0.00%−65,700−4.4%Reduced
Charles Schwab Investment Management Inc1,434,457$975.4K0.00%−31,702−2.2%Reduced
Two Sigma Investments, LP1,435,096$975.9K0.00%−102,259−6.7%Reduced
Ikarian Capital, LLC1,579,528$1.07M0.35%−449,500−22.2%Reduced
Mackenzie Financial Corp1,658,745$1.13M0.00%+1,188,976+253.1%Added
22NW, LP2,191,750$1.49M1.00%00.0%Unchanged
Exome Asset Management LLC2,232,453$1.52M1.36%+1,614,279+261.1%Added
Millennium Management LLC2,288,802$1.56M0.00%−2,236,144−49.4%Reduced
Jacobs Levy Equity Management, Inc3,007,928$2.05M0.01%+380,967+14.5%Added
State Street Corp3,258,290$2.22M0.00%−13,811−0.4%Reduced
AQR Capital Management LLC3,640,851$2.46M0.00%+2,807,595+336.9%Added
Woodline Partners LP3,691,878$2.51M0.02%−1,282,634−25.8%Reduced
TCG Crossover Management, LLC4,000,000$2.72M0.37%00.0%Unchanged
Geode Capital Management, LLC4,009,124$2.73M0.00%+51,538+1.3%Added
Almitas Capital LLC4,610,872$3.14M1.04%+3,690,647+401.1%Added
Renaissance Technologies LLC4,701,781$3.20M0.00%+790,995+20.2%Added
Primecap Management Co5,354,586$3.64M0.00%−185,800−3.4%Reduced
Eventide Asset Management, LLC6,650,000$4.52M0.09%00.0%Unchanged
Acadian Asset Management LLC7,301,734$4.96M0.01%+100,645+1.4%Added
Nantahala Capital Management, LLC7,789,051$5.30M0.44%−20,949−0.3%Reduced
Vanguard Group Inc12,309,688$8.37M0.00%−18,334−0.1%Reduced
BlackRock, Inc.15,707,325$10.7M0.00%−384,256−2.4%Reduced
Samlyn Capital, LLC0$00.00%−9,667,048−100.0%Sold out
Deep Track Capital, LP0$00.00%−1,975,998−100.0%Sold out
Diadema Partners LP0$00.00%−698,919−100.0%Sold out
Wellington Management Group LLP0$00.00%−522,409−100.0%Sold out
Shay Capital LLC0$00.00%−352,204−100.0%Sold out
Marquette Asset Management, LLC0$00.00%−158,809−100.0%Sold out
Persistent Asset Partners Ltd0$00.00%−166,572−100.0%Sold out
Squarepoint Ops LLC0$00.00%−139,758−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−65,759−100.0%Sold out
Bank of Montreal0$00.00%−54,500−100.0%Sold out
Moloney Securities Asset Management, LLC0$00.00%−50,000−100.0%Sold out
Harvest Investment Services, LLC0$00.00%−29,244−100.0%Sold out
Two Sigma Securities, LLC0$00.00%−27,654−100.0%Sold out
Neuberger Berman Group LLC0$00.00%−20,522−100.0%Sold out
R Squared Ltd0$00.00%−3,720−100.0%Sold out
Federated Hermes, Inc.0$00.00%−1,256−100.0%Sold out
Cornerstone Planning Group LLC0$00.00%−5−100.0%Sold out
Nuveen Asset Management, LLC––––Not filed
Global Retirement Partners, LLC––––Not filed